Nonalcoholic fatty liver disease and the epidemic of obesity

Article Type
Changed
Mon, 10/08/2018 - 11:14
Display Headline
Nonalcoholic fatty liver disease and the epidemic of obesity
Article PDF
Author and Disclosure Information

Rochelle Collantes, MD, MPH
Research Associate, Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, VA

Janus P. Ong, MD
Staff Hepatologist, Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, VA

Zobair M. Younossi, MD, MPH
Director, Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, VA

Address: Zobair M. Younossi, MD, MPH, Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042-3300

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Issue
Cleveland Clinic Journal of Medicine - 71(8)
Publications
Topics
Page Number
657-664
Sections
Author and Disclosure Information

Rochelle Collantes, MD, MPH
Research Associate, Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, VA

Janus P. Ong, MD
Staff Hepatologist, Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, VA

Zobair M. Younossi, MD, MPH
Director, Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, VA

Address: Zobair M. Younossi, MD, MPH, Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042-3300

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Author and Disclosure Information

Rochelle Collantes, MD, MPH
Research Associate, Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, VA

Janus P. Ong, MD
Staff Hepatologist, Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, VA

Zobair M. Younossi, MD, MPH
Director, Center for Liver Diseases at Inova Fairfax Hospital, Falls Church, VA

Address: Zobair M. Younossi, MD, MPH, Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042-3300

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 71(8)
Issue
Cleveland Clinic Journal of Medicine - 71(8)
Page Number
657-664
Page Number
657-664
Publications
Publications
Topics
Article Type
Display Headline
Nonalcoholic fatty liver disease and the epidemic of obesity
Display Headline
Nonalcoholic fatty liver disease and the epidemic of obesity
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

The role of physician extenders in managing patients with chronic hepatitis C

Article Type
Changed
Tue, 10/30/2018 - 12:15
Display Headline
The role of physician extenders in managing patients with chronic hepatitis C
Article PDF
Author and Disclosure Information

Harpreet Gujral, RN, MSN, CRNP
Center for Liver Diseases, Inova Fairfax Hospital, Fall Church, VA

Carla Viscomi, RN, BSN
Division of Gastroenterology, MetroHealth Medical Center, Cleveland, OH

Rochelle Collantes, MD, MPH
Center for Liver Diseases, Inova Fairfax Hospital, Fall Church, VA

Correspondence: Harpreet Gujral, RN, MSN, CRNP, Inova Fairfax Hospital, Center for Liver Diseases, Department of Medicine, 3300 Gallows Road, Falls Church, VA 22042; e-mail: harpreet.gujral@inova.com

Ms. Gujral reported that she serves as a consultant to the Schering-Plough corporation.

Ms. Viscomi and Dr. Collantes reported that they have no commercial affiliations or interests that pose a potential conflict of interest with this article.

Publications
Page Number
S33-S37
Author and Disclosure Information

Harpreet Gujral, RN, MSN, CRNP
Center for Liver Diseases, Inova Fairfax Hospital, Fall Church, VA

Carla Viscomi, RN, BSN
Division of Gastroenterology, MetroHealth Medical Center, Cleveland, OH

Rochelle Collantes, MD, MPH
Center for Liver Diseases, Inova Fairfax Hospital, Fall Church, VA

Correspondence: Harpreet Gujral, RN, MSN, CRNP, Inova Fairfax Hospital, Center for Liver Diseases, Department of Medicine, 3300 Gallows Road, Falls Church, VA 22042; e-mail: harpreet.gujral@inova.com

Ms. Gujral reported that she serves as a consultant to the Schering-Plough corporation.

Ms. Viscomi and Dr. Collantes reported that they have no commercial affiliations or interests that pose a potential conflict of interest with this article.

Author and Disclosure Information

Harpreet Gujral, RN, MSN, CRNP
Center for Liver Diseases, Inova Fairfax Hospital, Fall Church, VA

Carla Viscomi, RN, BSN
Division of Gastroenterology, MetroHealth Medical Center, Cleveland, OH

Rochelle Collantes, MD, MPH
Center for Liver Diseases, Inova Fairfax Hospital, Fall Church, VA

Correspondence: Harpreet Gujral, RN, MSN, CRNP, Inova Fairfax Hospital, Center for Liver Diseases, Department of Medicine, 3300 Gallows Road, Falls Church, VA 22042; e-mail: harpreet.gujral@inova.com

Ms. Gujral reported that she serves as a consultant to the Schering-Plough corporation.

Ms. Viscomi and Dr. Collantes reported that they have no commercial affiliations or interests that pose a potential conflict of interest with this article.

Article PDF
Article PDF
Page Number
S33-S37
Page Number
S33-S37
Publications
Publications
Article Type
Display Headline
The role of physician extenders in managing patients with chronic hepatitis C
Display Headline
The role of physician extenders in managing patients with chronic hepatitis C
Citation Override
Cleveland Clinic Journal of Medicine 2004 May;71(suppl 3):S33-S37
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media